GPT and alopecia: At the 400 mg b.i.d. dose level, the most common drug-related AEs were skin-related and hepatic disorders – HFS (50%), rash/desquamation (60%), pruritus (30%), alopecia (30%), abnormal AST (50%), ALT (50%), ALP (30%), and bilirubin (40%).